FBXL17 and neoplasm: In addition to breaks in tumours, array-CGH data showed breaks in FBXL17 in four cancer cell lines, the breast carcinoma cell lines, BT-474, HCC38, and HCC1395, and the oesophageal/gastric cardia adenocarcinoma line OE-19 [25].